Conference: 2021 CNS Annual Meeting

The purpose of the 2021 Annual Meeting of the Congress of Neurological Surgeons (CNS) is to provide continuing medical education for practicing neurosurgeons, neurosurgical residents in training and postgraduate neurosurgical fellows, as well as advanced practice providers including nurses, physician assistants and clinical specialists.

Featured Highlights

• Advanced Endoscopic and Exoscopic Neurosurgery Seminar
• Expanded Subspecialty Symposia
• Focus on Wellness and Resilience
• Cadaver Experiences
• Outstanding Guest Speakers
• Interactive Multimedia Presentation

Presenters

Brian V. Nahed, MD, MSc
Neurosurgeon | Neurosurgical Oncologist
Neurosurgical Oncology/Brain Tumor Surgeon/MGH Brain Tumor Center
Associate Professor, Harvard Medical School
Director, MGH Neurosurgery Residency Program

Frederick G. Barker, MD
Neurosurgeon | Neurosurgical Oncologist | Pediatric Neurosurgeon

Robert M. Richardson, MD, PhD
Neurosurgeon
Director, Functional Neurosurgery
Neurosurgery Faculty, Harvard Medical School
Visiting Associate Professor of Brain and Cognitive Sciences, Massachusetts Institute of Technology

William T. Curry, MD
Neurosurgeon | Neurosurgical Oncologist | Pediatric Neurosurgeon
Co-Director, Mass General Neuroscience
Director of Neurosurgical Oncology

Pamela S. Jones, MD, MPH
Neurosurgeon | Neurosurgical Oncologist
Assistant Professor of Neurosurgery, Harvard Medical School

Justin Brown, MD
Neurosurgeon | Pediatric Neurosurgeon | Reconstructive Surgeon
Director, MGH Paralysis Center

John H. Shin, MD
Spine Surgeon | Neurosurgeon
Kingdon-Saylor Family Endowed Chair in Spine Neurosurgery
Director, Spine Oncology and Spinal Deformity Surgery, Mass General Cancer Center
Director, Mass General Spine Neurosurgery Network

CNS is proud to announce Bob S. Carter, MD, PhD, Chair of the Department of Neurosurgery at Massachusetts General Hospital, as one of their Honored Guests at the 2021 CNS Annual Meeting.

Dr. Carter is one of the nation’s leading clinical neurosurgeons, Dr. Carter co-leads Massachusetts General Hospital’s brain tumor program, which is focused on brain tumor clinical care, research, and education. His work has included the development of EGFRvIII directed CAR T-cell therapy, the first characterizations of exosomes in glioblastoma, and the clinical development of novel iPS derived stem cell therapy for neurologic disorders. He has served as a principal investigator participating in the NIH-funded Extracellular RNA Communication Consortium and the NCI Liquid Biopsy Consortium. Dr. Carter leads a team of clinician scientists who have developed the role of “big data” in characterizing outcomes in oncologic and vascular neurosurgery.

Dr. Carter is extensively published, and he lectures internationally on neurosurgery topics. He has co-chaired the editorial board for the Journal of Neurosurgery and served as editorial advisory board member for Neurosurgery. Dr. Carter is known for his interest in professional mentorship, and career development of resident and faculty colleagues, including several faculty who have gone on to serve as current chairs of departments of neurosurgery.

Dr. Carter is an active member of the Congress of Neurological Surgeons, the American Academy of Neurological Surgery, and the Society for Neurological Surgeons, as well as a fellow of the American Association of Neurological Surgeons. He has served on the program committee for the American Stroke Association’s International Stroke Conference and has served on the executive boards of the Joint Cerebrovascular Section and the New England Neurosurgical Society.